此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Comparison of Electrocautery and Scalpel Blade Incisions of Impacted Mandibular Third Molars

2026年7月20日 更新者:Riphah International University

Comparison of Electrocautery and Scalpel Blade Incisions on Postoperative Pain, Intraoperative Blood Loss, and Wound Healing Following Surgical Extraction of Impacted Mandibular Third Molars: A Randomized Controlled Trial

This randomized controlled trial aims to compare electrocautery and scalpel blade incisions during surgical extraction of impacted mandibular third molars. The study will evaluate postoperative pain, intraoperative blood loss, and wound healing in patients undergoing third molar surgery. A total of 78 participants will be randomly allocated in a 1:1 ratio to receive either a scalpel blade incision or an electrocautery incision under standardized surgical conditions.

研究概览

详细说明

Surgical extraction of impacted mandibular third molars is one of the most common procedures in oral and maxillofacial surgery. The type of incision used may influence postoperative outcomes, including pain, bleeding, and wound healing. Electrocautery offers simultaneous cutting and coagulation, potentially reducing intraoperative blood loss and improving surgical visibility, whereas scalpel incisions produce precise tissue cuts without thermal injury.

This prospective, two-arm, parallel-group, randomized controlled trial will compare electrocautery and scalpel blade incisions in patients undergoing surgical extraction of impacted mandibular third molars. Seventy-eight participants will be randomly assigned to either Arm A (scalpel blade incision) or Arm B (electrocautery incision). All other surgical and perioperative variables, including local anesthesia, flap design, irrigation, suture material, and postoperative medications, will be standardized.

The primary outcome is postoperative pain assessed using a Visual Analogue Scale at 24 hours, 48 hours, and 7 days. Secondary outcomes include intraoperative blood loss and wound healing assessed using the Landry Wound Healing Index at 1 and 4 weeks. The findings of this study will provide evidence regarding the most appropriate incision technique for impacted mandibular third-molar surgery.

研究类型

介入性

注册 (估计的)

78

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

      • Islamabad、巴基斯坦、44000
        • Islamic International Dental Hospital
        • 接触:
        • 首席研究员:
          • Uzair Luqman, BDS/FCPS

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 孩子
  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Male and female patients.
  • Age 15 to 65 years.
  • Patients requiring surgical extraction of an impacted mandibular third molar. Patients classified as ASA I or ASA II.
  • Patients willing to provide written informed consent, or assent with parent/guardian permission where applicable, and attend scheduled follow-up visits

Exclusion Criteria:

  • * Patients with uncontrolled systemic disease or immuno-compromised status.

    • Patients with bleeding disorders or those taking anticoagulant/antiplatelet drugs that cannot be safely withheld according to physician advice.
    • Patients with pacemaker or implanted electrical cardiac device.
    • Pregnant or lactating patients.
    • Patients with acute infection, pericoronitis, facial space infection, or pus discharge at the surgical site at the time of surgery.
    • Patients requiring bilateral third-molar extraction in the same sitting.
    • Patients unwilling to participate or unable to return for follow-up.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:scalpel blade incision group
Participants will undergo surgical extraction of impacted mandibular third molars using a sterile No. 15 scalpel blade for the mucoperiosteal flap incision
A sterile No. 15 stainless-steel scalpel blade will be used to make the mucoperiosteal flap incision during surgical extraction of the impacted mandibular third molar.
实验性的:electrocautery incision group
Participants will undergo surgical extraction of impacted mandibular third molars using electrocautery in cutting mode for the mucoperiosteal flap incision
A fine electrocautery electrode in cutting mode at a standardized effective power setting will be used to make the mucoperiosteal flap incision during surgical extraction of the impacted mandibular third molar.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
postoperative pain
大体时间:24 hours, 48 hours, and 7 days after surgery.
Postoperative pain at the surgical site will be assessed using a 0-10 Visual Analogue Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain
24 hours, 48 hours, and 7 days after surgery.

次要结果测量

结果测量
措施说明
大体时间
intraoperative blood loss
大体时间:During surgery (from first incision to final suture).
Total blood loss will be calculated as the increase in gauze weight plus the suction-canister volume after subtracting the recorded irrigation volume. Results will be reported in milliliters (mL).
During surgery (from first incision to final suture).
wound healing
大体时间:1 week and 4 weeks after surgery.
Wound healing will be assessed using the Landry Wound Healing Index, scored from 1 (very poor) to 5 (excellent).
1 week and 4 weeks after surgery.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Uzair Luqman, BDS/FCPS、department of ORAL AND MAXILLOFACIAL SURGERY ISLAMIC INTERNATIONAL DENTAL HOSPITAL

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年8月1日

初级完成 (估计的)

2026年11月1日

研究完成 (估计的)

2026年12月1日

研究注册日期

首次提交

2026年7月20日

首先提交符合 QC 标准的

2026年7月20日

首次发布 (实际的)

2026年7月23日

研究记录更新

最后更新发布 (实际的)

2026年7月23日

上次提交的符合 QC 标准的更新

2026年7月20日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

其他研究编号

  • IIDC/IRC/2026/7/001

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Individual participant data will not be made publicly available

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅